Ex-Pharma Exec to Head HHS
Written by Editor   
Tuesday, November 14, 2017 07:27 AM

Former pharmaceutical company executive Alex Azar II is being nominated by President Trump to head the Department of Health and Human Services (HHS) and to preside over either the elimination or implementation of the Affordable Care Act (ACA).

Azar served as the HHS department’s general counsel from 2001 to 2005 in the George W. Bush administration and then as its deputy secretary, the number-two position, from 2005 to 2007.

It's his last high-profile job as president of Lilly USA, the largest affiliate of drugmaker Eli Lilly, however, that has raised the most eyebrows. If confirmed by the Senate, Azar will be Trump's lead person in dealing with Big Pharma. Azar worked at Eli Lilly for a decade after his stint at HHS.

HHS is now led by Acting Secretary Don Wright, MD, MPH. He took over in September after orthopedic surgeon Tom Price, MD, resigned while facing intense criticism and scrutiny for taking government trips on charter and military aircraft when less expensive commercial flights were available.


Source: https://www.medscape.com/viewarticle/888468?nlid=119053_3901&src=wnl_newsalrt_171113_MSCPEDIT&uac=151914AX&impID=1481678&faf=1